Article: A Report on Biosimilars as a Viable Market, as the Future of the Pharmaceutical Market Lies with Biotechnology.

M2 PRESSWIRE-26 September 2008-Research and Markets: A Report on Biosimilars as a Viable Market, as the Future of the Pharmaceutical Market Lies with Biotechnology(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:26092008

Dublin - Research and Markets (http://www.researchandmarkets.com/research/619c10/biosimilars_a_via) has announced the addition of the "Biosimilars: A Viable Market - But When?" report to their offering.

Providing

A thorough review of the latest regulatory situation in the USA, Europe and selected markets

An examination of products that are currently available for development:

- EPO

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!